Beta-amyloid Plaques May Appear in the Brain as Early as a Month After Birth
One of the most pressing mysteries of Alzheimer’s disease and other dementias is how long—and where—amyloid plaques have been developing, before the disease becomes…
One of the most pressing mysteries of Alzheimer’s disease and other dementias is how long—and where—amyloid plaques have been developing, before the disease becomes…
Researchers are getting closer to developing a simple blood test to diagnose Alzheimer’s disease. A study published in the journal JAMA Neurology found that…
If you or a loved one is going through the diagnostic process for Alzheimer’s, one of the terms you’re likely to hear quite a…
We’ll get to the important question of beta-amyloid plaque build-up, but first, the basics: What is beta-amyloid protein, what does beta-amyloid do in the…
In a new mice study, researchers showed that beta-amyloid — the toxic protein linked to Alzheimer’s — can gum up the olfactory system and…
In the 1990s, the idea that clumps of beta-amyloid proteins are the main culprits of Alzheimer’s took off, and this line of thought —…
The longstanding “amyloid hypothesis” suggests that Alzheimer’s hallmark beta-amyloid plaques and smaller clumps of beta-amyloid oligomers — proteins highly toxic to brain cells — can…
Researchers announced today that an Alzheimer’s clinical trial spearheaded by Washington University School of Medicine in St. Louis has been cancelled. Initial data analysis…
Much of Alzheimer’s research has focused on beta-amyloid plaques, one of the main drivers behind neurodegeneration in people with dementia. But more and more…
For the first time, researchers have discovered how beta-amyloid, the toxic protein that is often found in Alzheimer’s patients’ brains, affects the brain before…
When ancient Greek soldiers laid their mythical siege upon the city of Troy, they struggled to break through the city’s impenetrable walls. To finally…
A new clinical trial for Eli Lilly’s experimental ant-amyloid remternetug is aiming to change the fate of people with familial Alzheimer’s. There currently no…
Heralded as a longevity treatment for bio-hacking enthusiasts and tech CEOs, therapeutic plasma exchange also has applications for people concerned about inflammatory diseases like…
After months of delays, Alzheon gears up to present data from their pivotal Phase 3 drug trial, while Athira Pharma pays out a settlement…
ApoE4, a genetic variation sometimes referred to as the “Alzheimer’s gene,” is one of the most influential genetic risk factors for developing Alzheimer’s disease….